Skip to main content
Fuan Pharmaceutical (Group)co.,Ltd logo

Fuan Pharmaceutical (Group)co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,014 across all filing types
Latest filing 2018-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical (Group)co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于公司控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (832 characters) about the release of pledged shares by a controlling shareholder. It includes specific details about share pledge and release dates, shareholder names, and percentages of shares involved. There is no financial statement, no detailed financial analysis, no earnings data, no management discussion, and no mention of a report being attached or published. The content is about a change in share pledge status, which relates to capital structure but is more specifically about share pledge release rather than new financing or capital raising. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about share pledge status, which does not fit into more specific categories like Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA).
2018-04-26 Chinese
2018年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (368 characters) indicating that the company's 2018 first quarter report will be published on a future date (April 26, 2018) on a regulatory website. It does not contain the actual financial data or the report itself, but rather a notice to investors to check the forthcoming report. According to the 'MENU VS MEAL' rule, such a brief notice about report availability is classified as a Report Publication Announcement (RPA).
2018-04-25 Chinese
2018年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 年第一季度报告全文" which translates to "2018 First Quarter Report Full Text." It contains detailed financial data including income, profit, cash flow, asset and liability changes, shareholder information, risk disclosures, and management commentary on business performance for the first quarter of 2018. The presence of comprehensive financial statements and analysis for a quarterly period clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data and detailed explanations, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2018
2018-04-25 Chinese
董事辞职公告
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the resignation of a company director, Mr. Wen Min, from the board of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It includes details about the resignation date, the director's shareholding, compliance with relevant laws, and the impact on the board's operation. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of other types of filings such as earnings, annual reports, or regulatory certifications. The content clearly fits the category of announcements about changes in the company's board of directors or senior management.
2018-04-25 Chinese
关于控股股东部分股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder. It details the number of shares pledged, the shareholder's identity, and the percentage of shares involved. There is no financial report, earnings data, or management discussion. The content fits the category of a regulatory announcement about share pledging, which is a capital/financing activity. Therefore, the document is best classified as a Capital/Financing Update (CAP). The document length is short but contains substantive information about financing activity, not just a notice or report publication.
2018-04-25 Chinese
2017年年度股东大会之法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2017 Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It details the procedures of convening and holding the AGM, the qualifications of attendees, the voting procedures, and the legality of the resolutions passed at the meeting. The document does not contain financial statements or detailed financial performance data but focuses on the legal compliance and validity of the AGM process and resolutions. It is not the AGM presentation materials themselves but a legal opinion related to the AGM. Given the content and purpose, this document best fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM or related to it. The document length (5214 characters) and detailed content support this classification with high confidence.
2018-04-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.